Adaptive Biotechnologies (ADPT) Asset Utilization Ratio (2019 - 2026)

Adaptive Biotechnologies has reported Asset Utilization Ratio for 8 years, with the latest figure at 0.58 in Q1 2026.

• Quarterly Asset Utilization Ratio rose 60.69% year-over-year to 0.58 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.58 (up 60.69% YoY) and the FY2025 annual result came in at 0.53, up 76.6% from the prior year.
• Asset Utilization Ratio rose to 0.58 in Q1 2026 per ADPT's latest filing, from 0.55 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.58 in Q1 2026 and troughed at 0.17 in Q1 2022.
• A 5-year average of 0.3 and a median of 0.22 in 2023 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio decreased 12.07% in 2023, then jumped 74.16% in 2024.
• Over 5 years, Asset Utilization Ratio stood at 0.21 in 2022, then fell by 12.07% to 0.19 in 2023, then surged by 74.16% to 0.33 in 2024, then surged by 69.36% to 0.55 in 2025, then grew by 5.05% to 0.58 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.58, 0.55, and 0.51 for Q1 2026, Q4 2025, and Q3 2025 respectively.